Christopher Friedel
Plus aucun poste en cours
Historique de carrière de Christopher Friedel
Anciens postes connus de Christopher Friedel
Sociétés | Poste | Début | Fin |
---|---|---|---|
APONTIS PHARMA AG | Directeur/Membre du Conseil | 01/01/2021 | 12/05/2022 |
Jazz Pharmaceuticals Germany GmbH
Jazz Pharmaceuticals Germany GmbH Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Germany GmbH is a company committed to advancing clinical knowledge through various types of research, including non-interventional studies. The company is based in Munich, Germany. The company adheres to established regulations, industry best practices, and internal policies to ensure the integrity of their sponsored research. Jazz Pharmaceuticals Germany is focused on improving patients' lives by developing and commercializing products that address unmet medical needs. The CEO of the company is Iain Robert McGill. | Directeur Général | 01/12/2020 | - |
Formation de Christopher Friedel
University of Gottingen | Doctorate Degree |
Statistiques
Internationale
Allemagne | 4 |
Opérationnelle
Director/Board Member | 1 |
Doctorate Degree | 1 |
Chief Executive Officer | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
APONTIS PHARMA AG | Health Technology |
Entreprise privées | 1 |
---|---|
Jazz Pharmaceuticals Germany GmbH
Jazz Pharmaceuticals Germany GmbH Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Germany GmbH is a company committed to advancing clinical knowledge through various types of research, including non-interventional studies. The company is based in Munich, Germany. The company adheres to established regulations, industry best practices, and internal policies to ensure the integrity of their sponsored research. Jazz Pharmaceuticals Germany is focused on improving patients' lives by developing and commercializing products that address unmet medical needs. The CEO of the company is Iain Robert McGill. | Health Technology |
- Bourse
- Insiders
- Christopher Friedel
- Expérience